Additional information
| Water Retention | Minimal |
|---|---|
| Hepatotoxicity | Low, but caution advised in patients with liver impairment |
| Lab Test | Plasma levels can be monitored, though not routinely done |
| Strength | 4 mg |
| Also known as | Galanthamine |
| Blood pressure | Can cause hypotension or hypertension |
| Trade name | Razadyne, Reminyl |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (4aS,6R,8aS)-5,6,9,10,11,12-Hexahydro-3-methoxy-11-methyl-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol |
| Formula | C17H21NO3 |
| Substance class | Alkaloid |
| Main action | Acetylcholinesterase inhibitor |
| Half-life | Approximately 7 hours |
| Dosage (medical) | Typically 8 mg to 24 mg per day, taken in two divided doses |
| Dosage (sports) | Not applicable |
| Effects | Enhances cognitive function, improves memory and attention |
| Side effects | Nausea, vomiting, dizziness, headache, and decreased appetite |
| Use in sports | Not typically used in sports |
| Manufacturer | Sun Pharmaceuticals Industries |
Reviews
There are no reviews yet.